Varicose veins are enlarged, twisted veins that usually appear in the legs and can cause discomfort or pain. Treatment options vary and can include lifestyle changes, compression stockings, and medical interventions. Companies involved in varicose veins treatment play a role in providing medical devices, pharmaceuticals, and interventional procedures to manage this condition.
Medtronic plc Launched the SynchroStar™ EV laser system, a new generation endovenous laser ablation (EVLA) system for treating varicose veins with improved efficiency and patient comfort.
Boston Scientific Corporation Received FDA approval for the Venefit™ V Closure™ System with ClosureFast™ Plus catheter, offering a faster and more efficient option for radiofrequency ablation of varicose veins.
Johnson & Johnson Acquired Scioderm, a company developing a novel foam sclerotherapy product for treating varicose veins, expanding its portfolio in this market.
Merz Aesthetics Launched the Varicose Vein Solution with Varithena™, a first-of-its-kind microneedle applicator for sclerotherapy treatment of varicose veins, offering potential advantages over traditional injection methods.
ClariVein Corporation Secured USD 35 million in new funding to support the commercialization of its Venclose™ system, a non-thermal, non-tumescent solution for varicose vein treatment.
List of Varicose Veins Treatment Key Companies in the Market
Varicose Veins Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)